Gu Han Medicine: Shareholder Sale Xian plans to increase holdings with an amount not less than 20 million yuan

LightningPacketLoss · 2026-03-10T06:59:10+00:00

Ancient Chinese Medicine Announcement: The controlling shareholder and concerted action partner Shanghai Sailuxian plans to increase their holdings of the company's shares by no less than 20 million yuan within the next 6 months. The method of increase will be flexibly adjusted based on market conditions.

LightningPacketLoss

2026-03-10 06:59:10

Abstract generation in progress

Recently, Guhan Pharmaceutical announced that one of its controlling shareholders’ concerted actors, Shanghai Sailuxian, plans to increase its holdings in the company within the next six months, with a minimum investment of 20 million yuan. The method of increase will be flexibly implemented based on market conditions.

(Guhan Pharmaceutical Announcement)

(Editor: Yang Yan, Lin Chen)

Keywords: Healthcare

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes